DOI:
10.1055/s-00040811
Neurologie up2date
LinksClose Window
References
Reilmann R, McGarry A, Grachev ID. et al. European Huntingtonʼs Disease Network, Huntington Study Group investigators.
Safety and efficacy of pridopidine in patients with Huntingtonʼs disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.
Lancet Neurol 2019;
18: 165-176
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.